Search

64 results for “Drug safety”

• Research LetterOpen Access

  Comparison of agreement and rational uses of the WHO and Naranjo adverse event causality assessment tools

  Niti Mittal, Mahesh C. Gupta

  Vol. 6 · Issue 2 · pp. 91–93

  https://doi.org/10.4103/0976-500X.155486
  Full text ↗PDF

• Research PaperOpen Access

  Comparison of the effectiveness and safety of cefpodoxime and ciprofloxacin in acute exacerbation of chronic suppurative otitis media: A randomized, open-labeled, phase IV clinical trial

  Arijit Ghosh, Utpal Jana, Ajoy Khaowas, Saumik Das, Ananya Mandal, Nina Das

  Vol. 3 · Issue 4 · pp. 320–324

  https://doi.org/10.4103/0976-500X.103689
  Full text ↗PDF

• CommentaryOpen Access

  The new factor Xa inhibitor: Apixaban

  Sangeeta Bhanwra, Kaza Ahluwalia

  Vol. 5 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.124409
  Full text ↗PDF

• Research PaperOpen Access

  Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety

  Rituparna Maiti, Jyothirmai Jaida, P. L. John Israel, Narendar Koyagura, Sruthi Mukkisa

  Vol. 2 · Issue 3 · pp. 150–157

  https://doi.org/10.4103/0976-500X.83278
  Full text ↗PDF

• Web WiseOpen Access

  Rat guide: A guide to health, medication use, breeding, and care of rats

  S. Parasuraman

  Vol. 2 · Issue 4 · pp. 313–4

  https://doi.org/10.4103/0976-500X.85932
  Full text ↗PDF

• Research PaperOpen Access

  Comparative Effect of Divided Doses of Adult Solid and Liquid Oral Formulations of Antiepileptic Drugs in the Management of Pediatric Epilepsy

  Ravi Prasad Nidanapu, Bascarane Tamijarassy, Subramanian Mahadevan, Batmanabane Gitanjali

  Vol. 8 · Issue 2 · pp. 54–61

  https://doi.org/10.4103/jpp.JPP_7_17
  Full text ↗PDF

• Research LetterOpen Access

  Nonsteroidal anti-inflammatory drugs causing local inflammation of tissue at the site of injection

  Anton Aleksandrovich Kasatkin, Alexandr A. Urakov, Ilya Aleksandrovich Lukoyanov

  Vol. 7 · Issue 1 · pp. 26–8

  https://doi.org/10.4103/0976-500X.179359
  Full text ↗PDF

• Review ArticleOpen Access

  Mesotherapy – The french connection

  Sivagnanam G

  Vol. 1 · Issue 1 · pp. 4–5

  https://doi.org/10.4103/0976-500X.64529
  Full text ↗PDF

• Review ArticleOpen Access

  Tapinarof: A Felicitous Discovery in Psoriasis Treatment

  Indumathi Prabath, Subhiksha Subramanian, Jamuna Rani

  Vol. 13 · Issue 3 · pp. 222–228

  https://doi.org/10.1177/0976500X221130851
  Full text ↗PDF

• Research PaperOpen Access

  Effect of Lorazepam in Reducing Psychological Distress and Anticipatory Nausea and Vomiting in Patients Undergoing Chemotherapy

  Aloysius James, Malini Muraleedharan Nair, Dhanya Susan Abraham, Joel Sunny Kovoor, Wesley M. Jose, Remya Reghu

  Vol. 8 · Issue 3 · pp. 112–5

  https://doi.org/10.4103/jpp.JPP_54_17
  Full text ↗PDF

• Research PaperOpen Access

  Comparison of efficacy, safety, and cost‑effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: A prospective, randomized, double‑blind, parallel group study

  Ganesh Dakhale, Yogesh Tathod, Seema Patel, Sonali Pimpalkhute, Latesh Raghute, Ajita Khamkar

  Vol. 7 · Issue 4 · pp. 171–176

  https://doi.org/10.4103/0976-500X.195901
  Full text ↗PDF

• Research PaperOpen Access

  Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety

  Rituparna Maiti, Jyothirmai Jaida, Jalelur Rahman, Rajasri Gaddam, Anuradha Palani

  Vol. 2 · Issue 4 · pp. 270–276

  https://doi.org/10.4103/0976-500X.85958
  Full text ↗PDF

• EditorialOpen Access

  Push, promote or educate…musings of a pharmacologist on drug promotion

  Chanolean Shashindran

  Vol. 5 · Issue 4 · pp. 225–226

  https://doi.org/10.4103/0976-500X.142427
  Full text ↗PDF

• ReportOpen Access

  Annual report on adverse events related with vaccines use in Calabria (Italy): 2012

  Orietta Staltari, Felisa Cilurzo, Benedetto Caroleo, Alexia Greco, Francesco Corasaniti, Maria Antonietta Genovesi, Luca Gallelli

  Vol. 4 · Issue Supplement 1 · pp. S61–S62

  https://doi.org/10.4103/0976-500X.120951
  Full text ↗PDF

• Review ArticleOpen Access

  Rituximab, a Safer Option for Rheumatoid Arthritis: A Comparison of the Reported Adverse Events of Approved Monoclonal Antibodies

  Sweety Sharma, Somnath Basu, Ramesh K. Goyal, Parbhat K. Sahoo, Rajani Mathur

  Vol. 13 · Issue 4 · pp. 330–340

  https://doi.org/10.1177/0976500X231154743
  Full text ↗PDF

• Review ArticleOpen Access

  Ustekinumab: In Psoriasis and Beyond—A Dermatological Perspective

  Aditya Kumar Bubna, Vinayak Viplav

  Vol. 15 · Issue 2 · pp. 105–121

  https://doi.org/10.1177/0976500X241240643
  Full text ↗PDF

• Research ArticleOpen Access

  Adverse Drug Reactions to Antifungals Used in the Management of COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis

  Smrati Tiwari, Zahaan Vakil

  Vol. 13 · Issue 2 · pp. 197–202

  https://doi.org/10.1177/0976500X221105759
  Full text ↗PDF

• Case ReviewOpen Access

  Nexavar®-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012

  Felisa Cilurzo, Orietta Staltari, Marinella Patanè, Michele Ammendola, Caterina Garaffo, Eugenio Donato Paola

  Vol. 4 · Issue 1 · pp. S86–S86

  https://doi.org/10.4103/0976-500X.120971
  Full text ↗PDF

• CorrespondenceOpen Access

  Adverse drug reaction of oseltamivir in pediatric patients

  Somsri Wiwanitkit, Viroj Wiwanitkit

  Vol. 3 · Issue 1 · pp. 81–81

  https://doi.org/10.4103/0976-500X.92507
  Full text ↗PDF

• Research PaperOpen Access

  Adverse drug reaction profile of oseltamivir in children

  Prashant S. Dalvi, Anil Singh, Hiren R. Trivedi, Suresh D. Mistry, Bhadresh R. Vyas

  Vol. 2 · Issue 2 · pp. 100–103

  https://doi.org/10.4103/0976-500X.81901
  Full text ↗PDF